Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Depression × Methylphenidate × Clear all

Phase

Phase 3 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Fatigue 5 Neoplasms 4 Brain Neoplasms 2 Asthenia 2 Recurrence 1 Neoplasm Metastasis 1 Gastrointestinal Neoplasms 1 Depression 1 Breast Neoplasms 1

Interventions

Vortioxetine 1 Vitamin E 1 Therapeutics 1 Sertraline 1 Psychiatric Rehabilitation 1 Pharmacogenomic Testing 1 Mindfulness 1 Methylphenidate 1 Ketamine 1 Hypericum extract LI 160 1 Escitalopram 1 Duloxetine Hydrochloride 1 Donepezil 1 Dehydroepiandrosterone 1 Counseling 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01497548 2011-12-22

Study of Methylphenidate as Add on Therapy in Depressed Cancer Patients

University of Malaya

Phase 3 Unknown

Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡